169 related articles for article (PubMed ID: 36827398)
1. Ganglioside GM3 prevents high fat diet-induced hepatosteatosis via attenuated insulin signaling pathway.
Tajima O; Fujita Y; Ohmi Y; Furukawa K; Furukawa K
PLoS One; 2023; 18(2):e0281414. PubMed ID: 36827398
[TBL] [Abstract][Full Text] [Related]
2. Enhanced insulin sensitivity in mice lacking ganglioside GM3.
Yamashita T; Hashiramoto A; Haluzik M; Mizukami H; Beck S; Norton A; Kono M; Tsuji S; Daniotti JL; Werth N; Sandhoff R; Sandhoff K; Proia RL
Proc Natl Acad Sci U S A; 2003 Mar; 100(6):3445-9. PubMed ID: 12629211
[TBL] [Abstract][Full Text] [Related]
3. Control of homeostatic and pathogenic balance in adipose tissue by ganglioside GM3.
Nagafuku M; Sato T; Sato S; Shimizu K; Taira T; Inokuchi J
Glycobiology; 2015 Mar; 25(3):303-18. PubMed ID: 25303960
[TBL] [Abstract][Full Text] [Related]
4. Synergistic inhibition of cell migration by tetraspanin CD82 and gangliosides occurs via the EGFR or cMet-activated Pl3K/Akt signalling pathway.
Li Y; Huang X; Zhang J; Li Y; Ma K
Int J Biochem Cell Biol; 2013 Nov; 45(11):2349-58. PubMed ID: 23968914
[TBL] [Abstract][Full Text] [Related]
5. Differential roles of gangliosides in malignant properties of melanomas.
Ohmi Y; Kambe M; Ohkawa Y; Hamamura K; Tajima O; Takeuchi R; Furukawa K; Furukawa K
PLoS One; 2018; 13(11):e0206881. PubMed ID: 30462668
[TBL] [Abstract][Full Text] [Related]
6. Interaction of the extracellular domain of the epidermal growth factor receptor with gangliosides.
Miljan EA; Meuillet EJ; Mania-Farnell B; George D; Yamamoto H; Simon HG; Bremer EG
J Biol Chem; 2002 Mar; 277(12):10108-13. PubMed ID: 11796728
[TBL] [Abstract][Full Text] [Related]
7. Compartmental organization of the synthesis of GM3, GD3, and GM2 in golgi membranes from neural retina cells.
Maxzúd MK; Maccioni HJ
Neurochem Res; 1997 Apr; 22(4):455-61. PubMed ID: 9130256
[TBL] [Abstract][Full Text] [Related]
8. Heme Oxygenase-1 May Affect Cell Signalling via Modulation of Ganglioside Composition.
Šmíd V; Šuk J; Kachamakova-Trojanowska N; Jašprová J; Valášková P; Józkowicz A; Dulak J; Šmíd F; Vítek L; Muchová L
Oxid Med Cell Longev; 2018; 2018():3845027. PubMed ID: 30327713
[TBL] [Abstract][Full Text] [Related]
9. Gangliosides GM1, GM2 and GM3 inhibit the platelet-derived growth factor-induced signalling transduction pathway in vascular smooth muscle cells by different mechanisms.
Sachinidis A; Kraus R; Seul C; Meyer zu Brickwedde MK; Schulte K; Ko Y; Hoppe J; Vetter H
Eur J Cell Biol; 1996 Sep; 71(1):79-88. PubMed ID: 8884181
[TBL] [Abstract][Full Text] [Related]
10. Cloned beta 1,4 N-acetylgalactosaminyltransferase synthesizes GA2 as well as gangliosides GM2 and GD2. GM3 synthesis has priority over GA2 synthesis for utilization of lactosylceramide substrate in vivo.
Lutz MS; Jaskiewicz E; Darling DS; Furukawa K; Young WW
J Biol Chem; 1994 Nov; 269(46):29227-31. PubMed ID: 7961890
[TBL] [Abstract][Full Text] [Related]
11. Ganglioside GM3 as a gatekeeper of obesity-associated insulin resistance: Evidence and mechanisms.
Lipina C; Hundal HS
FEBS Lett; 2015 Oct; 589(21):3221-7. PubMed ID: 26434718
[TBL] [Abstract][Full Text] [Related]
12. GM2/GD2 and GM3 gangliosides have no effect on cellular cholesterol pools or turnover in normal or NPC1 mice.
Li H; Turley SD; Liu B; Repa JJ; Dietschy JM
J Lipid Res; 2008 Aug; 49(8):1816-28. PubMed ID: 18450647
[TBL] [Abstract][Full Text] [Related]
13. Obesity causes a shift in metabolic flow of gangliosides in adipose tissues.
Tanabe A; Matsuda M; Fukuhara A; Miyata Y; Komuro R; Shimomura I; Tojo H
Biochem Biophys Res Commun; 2009 Feb; 379(2):547-52. PubMed ID: 19116132
[TBL] [Abstract][Full Text] [Related]
14. Targeting hepatic pyruvate dehydrogenase kinases restores insulin signaling and mitigates ChREBP-mediated lipogenesis in diet-induced obese mice.
Wu CY; Tso SC; Chuang JL; Gui WJ; Lou M; Sharma G; Khemtong C; Qi X; Wynn RM; Chuang DT
Mol Metab; 2018 Jun; 12():12-24. PubMed ID: 29656110
[TBL] [Abstract][Full Text] [Related]
15. Ganglioside GM3 participates in the pathological conditions of insulin resistance.
Tagami S; Inokuchi Ji J; Kabayama K; Yoshimura H; Kitamura F; Uemura S; Ogawa C; Ishii A; Saito M; Ohtsuka Y; Sakaue S; Igarashi Y
J Biol Chem; 2002 Feb; 277(5):3085-92. PubMed ID: 11707432
[TBL] [Abstract][Full Text] [Related]
16. Ganglioside expression in human pancreatic islets.
Dotta F; Colman PG; Lombardi D; Scharp DW; Andreani D; Pontieri GM; Di Mario U; Lenti L; Eisenbarth GS; Nayak RC
Diabetes; 1989 Nov; 38(11):1478-83. PubMed ID: 2695376
[TBL] [Abstract][Full Text] [Related]
17. Gangliosides and CD82 inhibit the motility of colon cancer by downregulating the phosphorylation of EGFR at different tyrosine sites and signaling pathways.
Huang X; Li Y; He X; Chen Y; Wei W; Yang X; Ma K
Mol Med Rep; 2020 Nov; 22(5):3994-4002. PubMed ID: 33000220
[TBL] [Abstract][Full Text] [Related]
18. Ganglioside synthase knockout in oncogene-transformed fibroblasts depletes gangliosides and impairs tumor growth.
Liu Y; Yan S; Wondimu A; Bob D; Weiss M; Sliwinski K; Villar J; Notario V; Sutherland M; Colberg-Poley AM; Ladisch S
Oncogene; 2010 Jun; 29(22):3297-306. PubMed ID: 20305696
[TBL] [Abstract][Full Text] [Related]
19. Antibody response after immunization with the gangliosides GM1, GM2, GM3, GD2 and GD3 in the mouse.
Livingston PO; Ritter G; Calves MJ
Cancer Immunol Immunother; 1989; 29(3):179-84. PubMed ID: 2731184
[TBL] [Abstract][Full Text] [Related]
20. Developmental changes in ganglioside composition and synthesis in embryonic rat brain.
Yu RK; Macala LJ; Taki T; Weinfield HM; Yu FS
J Neurochem; 1988 Jun; 50(6):1825-9. PubMed ID: 3131485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
